Show simple item record

dc.contributor.authorGiles, Sally J.; orcid: 0000-0003-1623-6029; email: sally.giles@manchester.ac.uk
dc.contributor.authorPanagioti, Maria
dc.contributor.authorRiste, Lisa
dc.contributor.authorCheraghi-Sohi, Sudeh
dc.contributor.authorLewis, Penny
dc.contributor.authorAdeyemi, Isabel
dc.contributor.authorDavies, Karen
dc.contributor.authorMorris, Rebecca
dc.contributor.authorPhipps, Denham
dc.contributor.authorDickenson, Christine
dc.contributor.authorAshcroft, Darren
dc.contributor.authorSanders, Caroline
dc.date.accessioned2021-09-15T15:22:37Z
dc.date.available2021-09-15T15:22:37Z
dc.date.issued2021-09-15
dc.date.submitted2020-10-26
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625864/13643_2021_Article_1800_nlm.xml?sequence=2
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625864/13643_2021_Article_1800.pdf?sequence=3
dc.identifier.citationSystematic Reviews, volume 10, issue 1, page 248
dc.identifier.urihttp://hdl.handle.net/10034/625864
dc.descriptionFrom Springer Nature via Jisc Publications Router
dc.descriptionHistory: received 2020-10-26, registration 2021-08-25, accepted 2021-08-25, pub-electronic 2021-09-15, online 2021-09-15, collection 2021-12
dc.descriptionPublication status: Published
dc.descriptionFunder: National Institute for Health Research; doi: http://dx.doi.org/10.13039/501100000272
dc.description.abstractAbstract: Background: The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people. Methods/design: Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics. Discussion: The review will summarise the literature relating to medication safety and visual impairment.
dc.languageen
dc.publisherBioMed Central
dc.rightsLicence for this article: http://creativecommons.org/licenses/by/4.0/
dc.sourceeissn: 2046-4053
dc.subjectProtocol
dc.subjectMedication safety
dc.subjectVisual impairment
dc.titleVisual impairment and medication safety: a protocol for a scoping review
dc.typearticle
dc.date.updated2021-09-15T15:22:36Z
dc.date.accepted2021-08-25


Files in this item

Thumbnail
Name:
13643_2021_Article_1800_nlm.xml
Size:
38.72Kb
Format:
XML
Thumbnail
Name:
13643_2021_Article_1800.pdf
Size:
659.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record